These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11329519)

  • 1. A dog's breakfast: prescription drug coverage varies widely across Canada.
    Anis AH; Guh D; Wang Xh
    Med Care; 2001 Apr; 39(4):315-26. PubMed ID: 11329519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inter-provincial variation in government drug formularies.
    Grégoire JP; MacNeil P; Skilton K; Moisan J; Menon D; Jacobs P; McKenzie E; Ferguson B
    Can J Public Health; 2001; 92(4):307-12. PubMed ID: 11962119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of provincial prescription drug plans and the impact on patients' annual drug expenditures.
    Demers V; Melo M; Jackevicius C; Cox J; Kalavrouziotis D; Rinfret S; Humphries KH; Johansen H; Tu JV; Pilote L
    CMAJ; 2008 Feb; 178(4):405-9. PubMed ID: 18268266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Access to drugs for cancer: Does where you live matter?
    Menon D; Stafinski T; Stuart G
    Can J Public Health; 2005; 96(6):454-8. PubMed ID: 16350873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Family income and the impact of a children's health insurance program on reported need for health services and unmet health need.
    Feinberg E; Swartz K; Zaslavsky A; Gardner J; Walker DK
    Pediatrics; 2002 Feb; 109(2):E29. PubMed ID: 11826239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity of self-reported prescription drug insurance coverage.
    Grootendorst P; Newman EC; Levine MA
    Health Rep; 2003 Feb; 14(2):35-46. PubMed ID: 12658863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breadth, Depth and Agreement among Provincial Formularies in Canada.
    Morgan S; Hanley G; Raymond C; Blais R
    Healthc Policy; 2009 May; 4(4):e162-84. PubMed ID: 20436800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability in prescription medication coverage for children and youth across Canada: A scoping review.
    Ahmad A; Abbas M; Miregwa B; Holbrook AM
    Health Policy; 2022 Mar; 126(3):269-279. PubMed ID: 35140016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A synthesis of drug reimbursement decision-making processes in organisation for economic co-operation and development countries.
    Barnieh L; Manns B; Harris A; Blom M; Donaldson C; Klarenbach S; Husereau D; Lorenzetti D; Clement F
    Value Health; 2014; 17(1):98-108. PubMed ID: 24438723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of coxib formulary restrictions on analgesic use and cost: regional evidence from Canada.
    Marshall DA; Willison DJ; Grootendorst P; LeLorier J; Maclure M; Kulin NA; Sheehy OE; Warren L; Sykora K; Rahme E
    Health Policy; 2007 Nov; 84(1):1-13. PubMed ID: 17570558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Waiting for reimbursement of new medicines in Canada: it's time for a rethink.
    Skinner BJ
    Pharmacoeconomics; 2008; 26(8):629-32. PubMed ID: 18620457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in managed care drug formularies: what can consumers learn?
    Schweitzer SO
    Med Care Res Rev; 2000 Sep; 57(3):326-39. PubMed ID: 10981188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing patient access to pharmaceuticals in the UK and US.
    Cohen J; Cairns C; Paquette C; Faden L
    Appl Health Econ Health Policy; 2006; 5(3):177-87. PubMed ID: 17132032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of product listing agreements by Canadian provincial drug benefit plans.
    Morgan SG; Friesen MK; Thomson PA; Daw JR
    Healthc Policy; 2013 May; 8(4):45-55. PubMed ID: 23968637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparities in prescription drug insurance coverage.
    Millar WJ
    Health Rep; 1999; 10(4):11-31(ENG); 9-30(FRE). PubMed ID: 10607410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How does complementary private prescription drug insurance coverage affect seniors' use of publicly funded medications?
    Allin S; Law MR; Laporte A
    Health Policy; 2013 May; 110(2-3):147-55. PubMed ID: 23522381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does variation among provincial drug formulary antimicrobial listings in Canada influence prescribing rates?
    Glass-Kaastra SK; Finley R; Hutchinson J; Patrick DM; Weiss K; Conly J
    PLoS One; 2014; 9(9):e107515. PubMed ID: 25203557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naltrexone and pharmacy benefit management.
    Harris KM; Thomas C
    J Addict Dis; 2004; 23(4):11-29. PubMed ID: 15339711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescription drugs: issues of cost, coverage, and quality.
    Copeland C
    EBRI Issue Brief; 1999 Apr; (208):1-21. PubMed ID: 10539445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-related prescription nonadherence in the United States and Canada: a system-level comparison using the 2007 International Health Policy Survey in Seven Countries.
    Kennedy J; Morgan S
    Clin Ther; 2009 Jan; 31(1):213-9. PubMed ID: 19243719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.